---
schema_version: "secwatch.filing_event.v1"
accession: "0001035267-24-000203"
form_type: "8-K"
ticker: "ISRG"
cik: "0001035267"
company_name: "INTUITIVE SURGICAL INC"
filed_at: "2024-07-18T23:59:59+00:00"
generated_at: "2026-05-31T19:28:40.411397+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Intuitive Surgical Q2 revenue $2.01B (+14% YoY), GAAP EPS $1.46, non-GAAP $1.78

## Summary
- Revenue $2.01B (+14% YoY); GAAP net income $527M ($1.46 EPS), non-GAAP $641M ($1.78 EPS).
- Worldwide da Vinci procedures grew ~17% vs Q2 2023; placed 341 systems (incl. 70 da Vinci 5).
- Installed base grew 14% to 9,203 systems; instruments & accessories revenue $1.24B (+16%).
- Cash and investments $7.68B, up $360M in quarter; no COVID disruption in H1 2024.
- CEO cites healthy business, positive feedback on da Vinci 5 and adoption of SP and Ion.

## SEC filing metadata
- accession: 0001035267-24-000203
- form_type: 8-K
- ticker: ISRG
- cik: 0001035267
- company_name: INTUITIVE SURGICAL INC
- filed_at: 2024-07-18T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1035267/000103526724000203/0001035267-24-000203-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1035267/000103526724000203/isrg-20240718.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001035267-24-000203
- JSON: https://secwatch.observer/filing/0001035267-24-000203.json
- Plain text: https://secwatch.observer/filing/0001035267-24-000203.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.